Einträge von Herrlinger, Ulrich auf dem Publikationsserver

Weller, Johannes , Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael , Hau, Peter , Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich und Schneider, Matthias (2022) Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. Journal of Neuro-Oncology 159 (1), S. 95-101.

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael , Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Güresir, Erdem, Schmid, Matthias , Schuss, Patrick , Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank , Herrlinger, Ulrich und Schneider, Matthias (2022) Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial. Trials 23 (1). Volltext nicht vorhanden.

Schäfer, Niklas, Bumes, Elisabeth , Eberle, Fabian , Fox, Viola, Gessler, Florian, Giordano, Frank A., Konczalla, Juergen, Onken, Julia, Ottenhausen, Malte, Scherer, Moritz, Schneider, Matthias, Vatter, Hartmut, Herrlinger, Ulrich und Schuss, Patrick (2021) Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey. Journal of Neuro-Oncology 153 (3), S. 479-485.

Tzaridis, Theophilos , Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich und Felsberg, Jörg (2021) MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial. International Journal of Cancer 148 (7), S. 1695-1707. Volltext nicht vorhanden.

van den Bent, Martin J., Tesileanu, C. Mircea S. , Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Erridge, Sarah, Vogelbaum, Michael A., Nowak, Anna K. , Baurain, Jean Français, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter , Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B., Dubbink, Hendrikus Jan, Kros, Johan M., Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G. (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. The Lancet Oncology 22 (6), S. 813-823. Volltext nicht vorhanden.

Hau, Peter, Dirven, Linda, Luerding, Ralf, Beier, Dagmar, Bumes, Elisabeth, Reinert, Christiane, Seidel, Clemens, Bonsanto, Matteo Mario, Bremer, Michael, Rieken, Stefan, Combs, Stephanie E., Herrlinger, Ulrich, Seliger, Corinna, Kuntze, Holger, Mayer‑Steinacker, Regine, Dieing, Annette, Bartels, Claudius, Schnell, Oliver, Weyerbrock, Astrid, Seidel, Sabine, Grauer, Oliver, Nadji‑Ohl, Minou, Paulsen, Frank , Weller, Michael und Wick, Wolfgang (2020) Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. Journal of Neuro-Oncology 148, S. 117-130.

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. Journal of Neuro-Oncology 144 (3), S. 501-509. Volltext nicht vorhanden.

Weller, Johannes , Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert , Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich und Schäfer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology 20 (10), S. 1444-1453. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter , Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589. Volltext nicht vorhanden.

van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet 390 (10103), S. 1645-1653. Volltext nicht vorhanden.

Beier, Dagmar, Proescholdt, Martin, Reinert, Christiane, Pietsch, Torsten, Jones, David T. W. , Pfister, Stefan M. , Hattingen, Elke , Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter (2017) Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro-Oncology 20 (3), S. 400-410. Volltext nicht vorhanden.

Schäfer, Niklas, Proescholdt, Martin, Steinbach, Joachim P, Weyerbrock, Astrid, Hau, Peter , Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W, Uhl, Martin, Grau, Stefan, Hänel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos, Nießen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin und Herrlinger, Ulrich (2017) Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology 20 (7), S. 975-985. Volltext nicht vorhanden.

Herrlinger, Ulrich, Schäfer, Niklas, Steinbach, Joachim P. , Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W. , Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Hänel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Rüdiger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tüttenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter und Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. Journal of Clinical Oncology 34 (14), S. 1611-1619. Volltext nicht vorhanden.

Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian , Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. und Wirsching, Hans-Georg (2016) Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial. Neuro-Oncology 18 (4), S. 549-556. Volltext nicht vorhanden.

Hutterer, Markus, Nowosielski, Martha, Haybaeck, Johannes, Embacher, Sabine, Stockhammer, Florian, Gotwald, Thaddäus, Holzner, Bernhard, Capper, David, Preusser, Matthias, Marosi, Christine, Oberndorfer, Stefan, Moik, Martin, Buchroithner, Johanna, Seiz, Marcel, Tuettenberg, Jochen, Herrlinger, Ulrich, Wick, Antje, Vajkoczy, Peter und Stockhammer, Günther (2014) A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology 16 (1), S. 92-102. Volltext nicht vorhanden.

Glas, Martin, Hennemann, Burkhard, Hirschmann, Birgit, Marienhagen, Jörg, Schmidt-Wolf, Ingo, Herrlinger, Ulrich, Bogdahn, Ulrich und Hau, Peter (2008) Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma. Acta oncologica 47 (3), S. 479-480. Volltext nicht vorhanden.

Glas, Martin, Koch, Horst, Hirschmann, Birgit, Jauch, Tanja, Steinbrecher, Andreas, Herrlinger, Ulrich, Bogdahn, Ulrich und Hau, Peter (2007) Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series. Oncology 72 (5-6), S. 302-307. Volltext nicht vorhanden.

Herrlinger, Ulrich, Steinbrecher, A., Rieger, J., Hau, Peter, Kortmann, R.-D., Meyermann, R., Schabet, M., Bamberg, M., Dichgans, J., Bogdahn, U. und Weller, M. (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. Journal of neurology 252 (3), S. 291-299. Volltext nicht vorhanden.